Generation Investment Management has led the Swisscom-backed genomic testing platform developer's latest round, boosting its overall funding to $140m.
Switzerland-based genomics technology provider Sophia Genetics, which counts telecommunications firm Swisscom among its shareholders, has raised $77m in funding from new and existing investors.
Investment firm Generation Investment Management led the round, which included private equity firm Idinvest Partners, venture capital firm Balderton Capital and Alychlo, the investment vehicle for pharmaceutical entrepreneur Marc Coucke.
Founded in 2011, Sophia has developed a clinical genomics analytics platform intended to help healthcare professionals diagnose and treat patients for cancer and hereditary disorders by…
